X0305 4 2012-06-25 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001532219 Quinn Anthony 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421 false true false false SVP, Chief Medical Officer Common Stock 2012-06-25 4 S false 26000 40.649 D 20035 D The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 24, 2012. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $40.00 to $40.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. /s/ Anthony Quinn 2012-06-27